Eli Lilly opposes push to pass Trump’s drug pricing deals into law, CEO says

Eli Lilly opposes the White House’s push to codify “most favored nation” drug pricing into law, CEO Dave Ricks said in an interview with CNBC.

Please follow us:

This post was originally published here